International Price Comparisons of Anticancer Drugs: A Scheme for Improving Patient Accessibility.

The prices of anticancer drugs in Korea were similar to the lowest prices among the seven other study countries. A pre-listing and post-evaluation scheme should be considered to improve patient access to novel anticancer drugs by reducing the reimbursement review time and uncertainties.